Overview

Exenatide for Myocardial Protection During Reperfusion Study

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the effect of exenatide on myocardial injury in patients undergoing emergent percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction or heart attack (STEMI).
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
AstraZeneca
Treatments:
Exenatide